[CAS NO. 69304-47-8]  Brivudine

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [69304-47-8]

Catalog
HY-13578
Brand
MCE
CAS
69304-47-8

DESCRIPTION [69304-47-8]

Overview

MDLMFCD00058585
Molecular Weight333.14
Molecular FormulaC11H13BrN2O5
SMILESOC[C@@H]1[C@H](C[C@H](N2C(NC(C(/C=C/Br)=C2)=O)=O)O1)O

For research use only. We do not sell to patients.

1 Publications Citing Use of MCE


Summary

Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster.


In Vitro

Brivudine is an analog of thymidine, and is incorporated into the viral DNA. It blocks the action of DNA polymerases, thus inhibiting viral replication. It has a stronger antiviral effect against the varicella-zoster virus compared with reference compounds such as aciclovir or penciclovir [1] . It has high, selective activity against varicella zoster virus (VZV), inhibiting VZV replication, possibly through competitive inhibition of viral DNA polymerase, or by acting as an alternative substrate to deoxythymidine triphosphate, causing viral DNA strand breakage [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

At a dose of 125 mg once daily, brivudine has proved to be superior to aciclovir with respect to reducing the period of new blister production, and has shortened the duration of post-herpetic neuralgia [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT00031616 NewBiotics|National Cancer Institute (NCI)
Colorectal Cancer
December 2001 Phase 1|Phase 2

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 200 mg/mL ( 600.35 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.0017 mL 15.0087 mL 30.0174 mL
5 mM 0.6003 mL 3.0017 mL 6.0035 mL
10 mM 0.3002 mL 1.5009 mL 3.0017 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 10 mg/mL (30.02 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 10 mg/mL (30.02 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 10 mg/mL (30.02 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

Uridine, 5-[(1E)-2-bromoethenyl]-2′-deoxy-
Uridine, 5-(2-bromoethenyl)-2′-deoxy-, (E)-
5-[(1E)-2-Bromoethenyl]-2′-deoxyuridine
BVDU
(E)-5-(2-Bromovinyl)deoxyuridine
(E)-5-O-(2-bromoethenyl)-2′-deoxyuridine
Brivudine
5-[(E)-2-Bromoethenyl]-2′-deoxyuridine
Helpin
(E)-5-(2-Bromovinyl)-2′-deoxyuridine
Brivudin
Bromovinyldeoxyuridine
RP 101